Develops drugs for sickle cell disease.
Jun 2026Revenue $15.5M/yrExpenses $11.0M/yr
No trend
Figures by year
Is Emmaus Life Sciences profitable?
Yes. In the 12 months to Jun 2026, revenue was $15.5M and expenses $11.0M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $12.5M | $12.2M | $231K |
| Dec 2024 | $16.7M | $18.5M | −$1.89M |
| Dec 2023 | $29.6M | $26.1M | $3.54M |
| Dec 2022 | $18.4M | $25.0M | −$6.59M |
| Dec 2021 | $20.6M | $26.7M | −$6.13M |
| Dec 2020 | $23.2M | $23.2M | −$32.0K |
| Dec 2019 | $22.8M | $27.3M | −$4.51M |
| Dec 2018 | $16.5M | $24.9M | −$8.45M |
| Sep 2018 | $1.32M | $11.6M | −$10.2M |
| Sep 2017 | $129K | $7.23M | −$7.10M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.